AstraZeneca

Public AZN · United Kingdom

FollowEvery new trial, moved date and filing, and a Monday email
Furthest along
22 approved
21 in Phase 3
Next date
AZD1613, Phase 1 trial completes
Drugs
107
in active trials · 243 in all
Trials
372 active
944 since 2021

Drugs107

DrugHow it worksPartnerStageNext dateDetails
PD-L1 antibody
Approved 30 Nov 2026soonPhase 2 trial completes
CTLA-4 antibody
Approved 30 Nov 2026soonPhase 2 trial completes
—
Approved 10 Dec 2026soonPhase 2 trial completes
Monoclonal antibody
Approved 23 Dec 2026Phase 3 trial completes
Monoclonal antibody
Approved 6 Jan 2027Phase 3 trial completes
TROP2-targeted antibody-drug conjugate
Daiichi Sankyo
Approved 11 Jan 2027Phase 3 trial completes
EGFR inhibitor (third generation)
Approved 11 Jan 2027Phase 3 trial completes
Monoclonal antibody
Approved 13 Jan 2027Phase 3 trial completes
MET inhibitor
HUTCHMED
Approved in China 18 Jan 2027Phase 2 trial completes
—
Approved 3 Feb 2027Phase 4 trial completes
Monoclonal antibody
Daiichi Sankyo
Approved 10 Feb 2027Phase 2 trial completes
Acalabrutinibnot checked
Kinase inhibitor
Approved 15 Feb 2027Phase 3 trial completes
Sodium-Glucose cotransporter 2 inhibitor
Approved 18 Feb 2027Phase 3 trial completes
Poly(ADP-Ribose) polymerase inhibitor
Approved 6 Apr 2027Phase 3 trial completes
—
Approved 20 Apr 2027Phase 3 trial completes
—
Approved 31 May 2027Phase 4 trial completes
—
Approved 1 Nov 2027Phase 3 trial completes
Estrogen receptor antagonist
Approved 1 Nov 2027Phase 3 trial completes
MEK inhibitor
Approved 30 Nov 2027Phase 1/2 trial completes
Transthyretin-directed RNA Interaction; antisense oligonucleotide
Ionis Pharmaceuticals
Approved 6 Feb 2029Phase 2 trial completes

See all 107 drugs

Sign in free to see the whole list. No card, no password.

Sign in free

SEC filings301

Since Jan 2024 · All on SEC.gov

About

No active trial
136 other drugs
Registry names
3 names in ClinicalTrials.gov
Sources
ClinicalTrials.gov updated 16 Nov 2026 · SEC filings Industry-sponsored drug trials since 2021 · Logos provided by Logo.dev

Follow AstraZeneca

Following is part of Solo: you see every change to AstraZeneca the day it happens.

Solo

$49a month

  • Follow up to 5 landscapes, companies or drugs
  • Every change, the day it happens
  • A Monday email with the week’s changes
Choose Solo

Free

$0no card

  • One landscape of your own, in full
  • The top 10 of everything else
Sign up free

Have an account? Sign in